ArticleHemaSphere2025

Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high-risk relapsed/refractory Hodgkin lymphoma.

Matthew Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.